Seven Mile Advisory Astrazeneca PLC Transaction History
Seven Mile Advisory
- $136 Billion
- Q2 2024
A detailed history of Seven Mile Advisory transactions in Astrazeneca PLC stock. As of the latest transaction made, Seven Mile Advisory holds 3,421 shares of AZN stock, worth $221,304. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,421
Previous 3,043
12.42%
Holding current value
$221,304
Previous $206 Million
29.41%
% of portfolio
0.2%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,347Shares Held
491MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.2 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$2.76 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...